Clinical Center News
June / July 2023

Great Teachers lecture addresses perinatal depression research and treatment

Dr. Samantha Meltzer-Brody recognized as Distinguished Clinical Research Scholar

Dr. Samantha Meltzer-Brody holding award
Dr. Samantha Meltzer-Brody (second from right) was presented with the 2023 Great Teachers certificate by (l-r) Dr. Benjamin Solomon, the Clinical Center Medical Executive Committee chair and clinical director for the National Human Genome Research Institute, Dr. Maryland Pao, Distinguished Clinical Research Scholar and Educator in Research IC host and Clinical Director for the National Institute on Mental Health and Dr. Thomas Burklow, director of the Office of Clinical Research Training and Medical Education and the Medical Research Scholars Program.

On April 12, Dr. Samantha Meltzer-Brody was recognized as the 2023 Distinguished Clinical Research Scholar and Educator in Research (DCRSER). Meltzer-Brody, an internationally recognized physician-scientist in perinatal depression, is the Assad Meymandi Distinguished Professor and Chair of the Department of Psychiatry at the University of North Carolina (UNC) at Chapel Hill and directs the UNC Center for Women's Mood Disorders.

As the 2023 NIH Clinical Center's DCRSER honoree, Meltzer-Brody gave a "Great Teachers Lecture," a special session of the weekly Clinical Center Grand Rounds program.

The Great Teachers Lecture Series invites nationally recognized investigators and educators to share their expertise on topics while informing and inspiring principal investigators, staff clinicians, clinical researchers and research trainees.

Meltzer-Brody's presentation was entitled, "From Bench to Bedside: A Translational Approach to Innovation in Research and Treatment of Perinatal Depression."

Meltzer-Brody is an advocate for prenatal care, innovation and transformation of mental health care. Her research investigates the epidemiologic and biological predictors of perinatal depression including genetic, neurosteroid and other neuroendocrine biomarkers as well as the impact of adverse life events. She has been the academic Principal Investigator for novel clinical trials developing an effective new pharmacologic treatment for postpartum depression called brexanolone, which is now FDA approved.

Meltzer-Brody was named to the "2021 Forbes - The Visionary List: Women Over 50 Shaping the Future of Science, Technology and Art" and the Forbes List of ‘Women over 50 Working to Improve our Collective Mental Health." She was also ranked in 2021 by Expertscape, as the number one expert in the world for postpartum depression. Most recently, in June 2022, she was named to the Forbes list of 16 Healthcare Innovators You Should Know.

This lecture took place in person at Lipsett Amphitheater. Following the lecture, Dr. Benjamin Solomon, the Clinical Center Medical Executive Committee chair and clinical director for the National Human Genome Research Institute, presented a certificate of appreciation to Meltzer- Brody.

The lecture is archived and available for viewing on NIH Videocast.

- Janice Duran

You are now leaving the NIH Clinical Center website.

This external link is provided for your convenience to offer additional information. The NIH Clinical Center is not responsible for the availability, content or accuracy of this external site.

The NIH Clinical Center does not endorse, authorize or guarantee the sponsors, information, products or services described or offered at this external site. You will be subject to the destination site’s privacy policy if you follow this link.

More information about the NIH Clinical Center Privacy and Disclaimer policy is available at